SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Canadian Political Free-for-All
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gulo who wrote (3791)4/2/2004 7:26:03 PM
From: John Sladek  Read Replies (2) of 37075
 
Gulo, Guess again, the drug companies have some the fattest profit margins going.

so the drug development industry depends on higher prices in the U.S. to pay for their development programs.

Merk:
Profitability
Profit Margin (ttm): 29.30%
Operating Margin (ttm): 40.26%

Johnson & Johnson
Profitability
Profit Margin (ttm): 17.19%
Operating Margin (ttm): 24.62%

Forest Labs
Profitability
Profit Margin (ttm): 29.94%
Operating Margin (ttm): 38.44%

GlaxoSmithKline
Profitability
Profit Margin (ttm): 21.41%
Operating Margin (ttm): 29.81%

Pfizer
Profitability
Profit Margin (ttm): 3.63%
Operating Margin (ttm): 7.22%

BristolMyersSquibb
Profitability
Profit Margin (ttm): 16.65%
Operating Margin (ttm): 22.47%

Novartis
Profitability
Profit Margin (ttm): 22.63%
Operating Margin (ttm): 24.33%

Aventis
Profitability
Profit Margin (ttm): 10.97%
Operating Margin (ttm): 20.31%

Abbott
Profitability
Profit Margin (ttm): 13.99%
Operating Margin (ttm): 16.88%
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News